基因芯片在预测乳腺癌耐药性中的应用

下载PDF

导出

摘要本文对基因芯片包括c DNA芯片和寡核苷酸芯片等在乳腺癌研究中的应用做一综述,包括预测乳腺癌对化疗的敏感性、对单抗联合化疗治疗的敏感性及其他方面的应用。

作者付静静

机构地区江苏省徐州医药高等职业学校

出处《科技风》 2016年第15期9-9,共1页

关键词基因芯片 CDNA芯片寡核苷酸芯片曲妥珠单抗 Her2

参考文献7

1Chang J. C. et al., 2003.Gene expression profiling for the predictionof therapeutic response to docetaxel in patients with breast cancer. Lancet362:362-369.
2Cleator S. et al., 2006. Gene expression patterns for doxorubicin(Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance.Breast Cancer Res.Treat.95:229-233.
3Potti A. et al., 2006. Genomic signatures to guide the use ofchemotherapeutics. Nature Medicine 12:1294-1300.
4Ayers M. et al., 2004. Gene Expression Profiles Predict CompletePathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin,and Cyclophosphamide Chemotherapy in Breast Cancer. J. Clin. Oncol.22: 2284-2293.
5Iwao-Koizumi K. et al., 2005. Prediction of Docetaxel Response inHuman Breast Cancer by Gene Expression Profiling. J. Clin. Oncol. 23:422-431.
6Thuerigen O. et al., 2006. Gene Expression Signature PredictingPathologic Complete Response With Gemcitabine, Epirubicin, and Docetaxelin Primary Breast Cancer. J. Clin. Oncol. 24: 1839-1845.
7Koike Folgueira M. A. A. et al., 2005. Gene Expression Profile Associatedwith Response to Doxorubicin-Based Therapy in Breast Cancer.Clin. Cancer Res. 11: 7434-7443.

科技风

2016年第15期

内容加载中请稍等...